It wasn't my primary point of concern, but I did touch on the FDA "modifications" with Don. The FDA is a typical bureaucracy from the way he described it. It seems that just when the compnay thinks they've satisfied all the requirements, another branch will inject itself in the process with a new list of demands to be met....almost like playing whack a mole.
I think they could have worded that news back on July 25th, but it does say they received an approval "pathway", so it seems the FDA might have added a few obstacles along that path, hurdles that still have to be cleared.
On a different note I'm noticing the bid/ask at $1.75 both ways.....obviously that will change, I don't have much faith in pre-market quotes, but hopefully we see a gap up.